The autoreactive and neuro-inflammatory disease therapy developer closed a $77.5m round co-led by Sanofi Ventures that took its total funding to more than $117m.

The precision medicine developer attracted returning investors Novo, Novartis Venture Fund and Johnson & Johnson Innovation – JJDC for a crossover financing round.

The e-commerce marketplace secured $80m in a round led by Naver and backed by its Mirae Asset-Naver Asia Growth Fund at a post-money valuation topping $900m.

The online insurer took its total valuation to $500m in a round led by Munich Re Ventures and backed by fellow corporate investors Amazon and Intact Financial.

Escape Bio, a spinout of Gladstone Institutes, has secured the return of Osage University Partners, Novartis, Novo and Johnson & Johnson.

The investment firm supplied $50m for telehealth platform developer MDLive, which already counts Sentara, Cigna, Sutter Health, Novo and HCSC as investors.

The Johns Hopkins spinout has raised cash from OUP as it looks to move its first candidate, targeting skin itch complications, into the clinic.

The electric vehicle producer received $73.1m from SAIC's parent company as it reportedly mulls an initial public offering that could value it at $4.3bn.

Merck Global Health Innovation Fund has contributed to a $47.5m round for AeroSafe Global, which provides cold supply chain services to pharmaceutical clients.

BMW, Dell and Robert Bosch all returned for a $75m round that brought the manufacturing marketplace’s overall equity financing to $193m.